Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $988000.0.

  • Pediatrix Medical's Other Working Capital Changes rose 14406.78% to $988000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year increase of 24900.88%. This contributed to the annual value of -$3.5 million for FY2024, which is 49392.56% down from last year.
  • Per Pediatrix Medical's latest filing, its Other Working Capital Changes stood at $988000.0 for Q3 2025, which was up 14406.78% from -$1.3 million recorded in Q2 2025.
  • Over the past 5 years, Pediatrix Medical's Other Working Capital Changes peaked at $47.8 million during Q1 2021, and registered a low of -$88.6 million during Q2 2021.
  • Its 5-year average for Other Working Capital Changes is -$3.2 million, with a median of -$832000.0 in 2022.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first surged by 741421.32% in 2021, then tumbled by 260754.72% in 2025.
  • Quarter analysis of 5 years shows Pediatrix Medical's Other Working Capital Changes stood at -$15.1 million in 2021, then skyrocketed by 144.79% to $6.8 million in 2022, then tumbled by 44.31% to $3.8 million in 2023, then crashed by 35.17% to $2.4 million in 2024, then crashed by 59.64% to $988000.0 in 2025.
  • Its Other Working Capital Changes stands at $988000.0 for Q3 2025, versus -$1.3 million for Q2 2025 and $1.1 million for Q1 2025.